Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1481

1.

Regional cerebral infusion for acute ischemic stroke.

Wu C, Huber C, Huber M, Xu S, Ji X.

Brain Circ. 2019 Dec 27;5(4):241-243. doi: 10.4103/bc.bc_61_19. eCollection 2019 Oct-Dec. No abstract available.

2.

Evidence and opportunities of hypothermia in acute ischemic stroke: Clinical trials of systemic versus selective hypothermia.

Huber C, Huber M, Ding Y.

Brain Circ. 2019 Dec 27;5(4):195-202. doi: 10.4103/bc.bc_25_19. eCollection 2019 Oct-Dec. Review.

3.

Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel.

Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K.

J Travel Med. 2020 Jan 14. pii: taaa008. doi: 10.1093/jtm/taaa008. [Epub ahead of print]

PMID:
31943059
4.

Cardiorespiratory Fitness, Sleep, and Physiological Responses to Stress in Women.

Crowley SK PhD, Rebellon J BS, Huber C BS, Leonard AJ BS, Henderson D PhD, Magal M PhD.

Eur J Sport Sci. 2020 Jan 15:1-27. doi: 10.1080/17461391.2020.1716855. [Epub ahead of print]

PMID:
31939334
5.

Biallelic variants in KYNU cause a multisystemic syndrome with hand hyperphalangism.

Ehmke N, Cusmano-Ozog K, Koenig R, Holtgrewe M, Nur B, Mihci E, Babcock H, Gonzaga-Jauregui C, Overton JD, Xiao J, Martinez A, Muenke M, Balzer A, Jochim J, El Choubassi N, Fischer-Zirnsak B, Huber C, Kornak U, Elsea S, Cormier-Daire V, Ferreira CR.

Bone. 2020 Jan 7:115219. doi: 10.1016/j.bone.2019.115219. [Epub ahead of print]

PMID:
31923704
6.

Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein.

Padutsch T, Sendetski M, Huber C, Peters N, Pfizenmaier K, Bethea JR, Kontermann RE, Fischer R.

Front Pharmacol. 2019 Dec 18;10:1490. doi: 10.3389/fphar.2019.01490. eCollection 2019.

7.

Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.

Chen YH, Grigelioniene G, Newton PT, Gullander J, Elfving M, Hammarsjö A, Batkovskyte D, Alsaif HS, Kurdi WIY, Abdulwahab F, Shanmugasundaram V, Devey L, Bacrot S, Brodszki J, Huber C, Hamel B, Gisselsson D, Papadogiannakis N, Jedrycha K, Gürtl-Lackner B, Chagin AS, Nishimura G, Aschenbrenner D, Alkuraya FS, Laurence A, Cormier-Daire V, Uhlig HH.

J Exp Med. 2020 Mar 2;217(3). pii: e20191306. doi: 10.1084/jem.20191306.

PMID:
31914175
8.

Influence of Melt-Pool Stability in 3D Printing of NdFeB Magnets on Density and Magnetic Properties.

Skalon M, Görtler M, Meier B, Arneitz S, Urban N, Mitsche S, Huber C, Franke J, Sommitsch C.

Materials (Basel). 2019 Dec 29;13(1). pii: E139. doi: 10.3390/ma13010139.

9.

Motor tract integrity predicts walking recovery: A diffusion MRI study in subacute stroke.

Soulard J, Huber C, Baillieul S, Thuriot A, Renard F, Aubert Broche B, Krainik A, Vuillerme N, Jaillard A; ISIS-HERMES Group.

Neurology. 2020 Jan 2. pii: 10.1212/WNL.0000000000008755. doi: 10.1212/WNL.0000000000008755. [Epub ahead of print]

PMID:
31896618
10.

Design-features of bubble-prone experimental asset markets with a constant FV.

Huber C, Bindra PC, Kleinlercher D.

J Econ Sci Assoc. 2019;5(2):197-209. doi: 10.1007/s40881-019-00061-5. Epub 2019 Mar 26.

11.

Comparison of different technologies for the decipherment of the whole genome sequence of Campylobacter jejuni BfR-CA-14430.

Epping L, Golz JC, Knüver MT, Huber C, Thürmer A, Wieler LH, Stingl K, Semmler T.

Gut Pathog. 2019 Dec 16;11:59. doi: 10.1186/s13099-019-0340-7. eCollection 2019.

12.

Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database.

Huber CA, Agosti R, Näpflin M, Blozik E.

Pharmacoepidemiol Drug Saf. 2019 Dec 11. doi: 10.1002/pds.4938. [Epub ahead of print]

PMID:
31828875
13.

A new case of KIAA0753-related variant of Jeune asphyxiating thoracic dystrophy.

Faudi E, Brischoux-Boucher E, Huber C, Dabudyk T, Lenoir M, Baujat G, Michot C, Van Maldergem L, Cormier-Daire V, Piard J.

Eur J Med Genet. 2019 Dec 7:103823. doi: 10.1016/j.ejmg.2019.103823. [Epub ahead of print] Review.

PMID:
31816441
14.

Could Animal-Assisted Therapy Help to Reduce Coercive Treatment in Psychiatry?

Widmayer S, Borgwardt S, Lang UE, Huber CG.

Front Psychiatry. 2019 Nov 14;10:794. doi: 10.3389/fpsyt.2019.00794. eCollection 2019. Review.

15.

Multiplex malaria antigen detection by bead-based assay and molecular confirmation by PCR shows no evidence of Pfhrp2 and Pfhrp3 deletion in Haiti.

Herman C, Huber CS, Jones S, Steinhardt L, Plucinski MM, Lemoine JF, Chang M, Barnwell JW, Udhayakumar V, Rogier E.

Malar J. 2019 Nov 27;18(1):380. doi: 10.1186/s12936-019-3010-9.

16.

Reduction of Involuntary Admissions in Patients With Severe Psychotic Disorders Treated in the ACCESS Integrated Care Model Including Therapeutic Assertive Community Treatment.

Schöttle D, Ruppelt F, Schimmelmann BG, Karow A, Bussopulos A, Gallinat J, Wiedemann K, Luedecke D, Rohenkohl AC, Huber CG, Bock T, Lambert M.

Front Psychiatry. 2019 Oct 24;10:736. doi: 10.3389/fpsyt.2019.00736. eCollection 2019.

17.

Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries.

Miller KM, Hermann J, Foster N, Hofer SE, Rickels MR, Danne T, Clements MA, Lilienthal E, Maahs DM, Holl RW; T1D Exchange and DPV Registries.

Diabetes Care. 2020 Jan;43(1):e1-e2. doi: 10.2337/dc19-1214. Epub 2019 Oct 31. No abstract available.

PMID:
31672703
18.

Boiling down the cysteine-stabilized LTP fold - loss of structural and immunological integrity of allergenic Art v 3 and Pru p 3 as a consequence of irreversible lanthionine formation.

Wildner S, Griessner I, Stemeseder T, Regl C, Soh WT, Stock LG, Völker T, Alessandri C, Mari A, Huber CG, Stutz H, Brandstetter H, Gadermaier G.

Mol Immunol. 2019 Dec;116:140-150. doi: 10.1016/j.molimm.2019.10.012. Epub 2019 Oct 22.

PMID:
31654938
19.

Expanding the phenotype in Adams-Oliver syndrome correlating with the genotype.

Dudoignon B, Huber C, Michot C, Di Rocco F, Girard M, Lyonnet S, Rio M, Rabia SH, Daire VC, Baujat G.

Am J Med Genet A. 2020 Jan;182(1):29-37. doi: 10.1002/ajmg.a.61364. Epub 2019 Oct 25.

PMID:
31654484
20.

Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.

Jochim A, Meindl T, Huber C, Mantel T, Zwirner S, Castrop F, Haslinger B.

J Neurol. 2020 Jan;267(1):267-275. doi: 10.1007/s00415-019-09581-w. Epub 2019 Oct 19.

PMID:
31630241

Supplemental Content

Loading ...
Support Center